Merck moves Seattle to Boston
When I heard that pharmaceutical company Merck was linkurl:slashing;http://www.the-scientist.com/blog/display/55103/ more than 7,000 jobs across the company, my thoughts immediately went to Eric Schadt and his colleagues at Rosetta Inpharmatics, a Seattle-based Merck subsidiary. I linkurl:profiled;http://www.the-scientist.com/article/display/54801/ Schadt, who heads the company's research genetics department, in our July issue. Recent linkurl:reports;http://www.genome-technology.com/issues/blog
Bob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
View Full Profile.
Learn about our Editorial Policies.
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Meet the Author
Bob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.View full profile
Share
